Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

ERS guidelines on the dia… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

Artikel i vetenskaplig tidskrift
Författare A. H. Morice
Eva Millqvist
K. Bieksiene
S. S. Birring
P. Dicpinigaitis
C. D. Ribas
M. H. Boon
A. Kantar
K. F. Lai
L. McGarvey
D. Rigau
I. Satia
J. Smith
W. J. Song
T. Tonia
J. W. K. van den Berg
M. J. G. van Manen
A. Zacharasiewicz
Publicerad i European Respiratory Journal
Volym 55
Nummer/häfte 1
Sidor 20
ISSN 0903-1936
Publiceringsår 2020
Publicerad vid Institutionen för medicin
Sidor 20
Språk en
Länkar dx.doi.org/10.1183/13993003.01136-2...
Ämnesord exhaled nitric-oxide, placebo-controlled trial, randomized, controlled-trial, refractory chronic cough, innate lymphoid-cells, inhaled corticosteroids, gastroesophageal-reflux, double-blind, eosinophilic bronchitis, respiratory symptoms, Respiratory System
Ämneskategorier Lungmedicin och allergi

Sammanfattning

These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella term that explains the exquisite sensitivity of patients to external stimuli such a cold air, perfumes, smoke and bleach. Thus, adults with chronic cough now have a firm physical explanation for their symptoms based on vagal afferent hypersensitivity. Different treatable traits exist with cough variant asthma (CVA)/eosinophilic bronchitis responding to anti-inflammatory treatment and non-acid reflux being treated with promotility agents rather the anti-acid drugs. An alternative antitussive strategy is to reduce hypersensitivity by neuromodulation. Low-dose morphine is highly effective in a subset of patients with cough resistant to other treatments. Gabapentin and pregabalin are also advocated, but in clinical experience they are limited by adverse events. Perhaps the most promising future developments in pharmacotherapy are drugs which tackle neuronal hypersensitivity by blocking excitability of afferent nerves by inhibiting targets such as the ATP receptor (P2X3). Finally, cough suppression therapy when performed by competent practitioners can be highly effective. Children are not small adults and a pursuit of an underlying cause for cough is advocated. Thus, in toddlers, inhalation of a foreign body is common. Persistent bacterial bronchitis is a common and previously unrecognised cause of wet cough in children. Antibiotics (drug, dose and duration need to be determined) can be curative. A paediatric-specific algorithm should be used.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?